LITAF and familial pancreatic carcinoma: In addition, in our epigenetic study of the LITAF promoter in pancreatic cancer cells and tissues, we noticed not all of pancreatic cancer cases and cells had the same reaction to aberrant methylation of LITAF promoter, indicating existence of different molecular subtypes.